
EUCR
Financial Services · Shell Companies · $42.2M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Apr 13, 2023 | Time not confirmed | — | 0.02 | — |
| Nov 14, 2022 | Time not confirmed | — | 0.04 | — |
| Aug 15, 2022 | Time not confirmed | — | 0.03 | — |
| Apr 11, 2022 | Time not confirmed | — | 0.02 | — |
| Nov 22, 2021 | Time not confirmed | — | 0.07 | — |
| Jul 16, 2021 | Time not confirmed | — | 0.15 | — |
| Jun 30, 2021 | Time not confirmed | — | 0.05 | — |
| Mar 31, 2021 | Time not confirmed | — | -0.01 | — |
| Dec 7, 2020 | Time not confirmed | — | 0.00 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -0.00 | — |
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is…